Author:
Shobha Vineeta,Jain Avinash,Chandrashekara S,Shenoy Padmanabha,Pandya SapanC,Chotalia Prakash,Kumar Sharath,Malviya Sourabh,Singh YogeshPreet,Patil Abhishek,Gupta Vikas,Srivastava Puja,Parimi VijayaPrasanna,Kodishala Chanakya,Janardana Ramya,Pinto Benzeeta,Bhandari Sudhir,Rankawat Govind,Jadhav PraveenPratap,Potugari Damodaram,Sharma Vishnu,Parmar Alpana,Kayidhi Sunitha,Antony PaulT,Badika Ashish,Sharma Amit
Reference24 articles.
1. Weekly Epidemiological Update – 29 December 2020. Available from: https://www.who.int/publications/m/item/weekly-epidemiological-update---29-december-2020. [Last accessed on 2022 Mar 07].
2. Rheumatic disease and COVID-19: epidemiology and outcomes.Nat Rev Rheumatol;Hyrich,2021
3. Dexamethasone in hospitalized patients with COVID-19;The;N Engl J Med,2021
4. Tocilizumab in Patients Hospitalized with COVID-19 Pneumonia;Salama;N Engl J Med,2021
5. Tocilizumab in patients with severe COVID-19: A retrospective cohort study;Guaraldi;Lancet Rheumatol,2020